Log In
BCIQ
Print this Print this
 

JBM-TC4

  Manage Alerts
Collapse Summary General Information
Company Joben Bio-Medical Co. Ltd.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDermatitis
Indication DetailsTreat and prevent acute radiation-induced dermatitis in breast cancer patients receiving radiotherapy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today